Anand Padmanabhan: A New Concise Nutshell Review of MGTS as an Emerging Thrombophilia
Anand Padmanabhan, Professor and Clinician-Investigator at Mayo Clinic, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“We are excited to share our new ‘nutshell’ review on a new thrombotic condition Monoclonal Gammopathy of Thrombotic Significance (MGTS)—a concise (~1000 words) and accessible overview of this emerging thrombophilia.
Congratulations to the authors Adam Kanack, Emily Armstrong, and David Murray on this excellent work!
MGTS is a rapidly evolving entity that we first described a few years ago, and our understanding continues to grow. This review highlights three key subtypes:
- HIT-like
- VITT-like
- Non-HIT/VITT-like
Recognizing these distinct phenotypes is critical—accurate diagnosis is the first step toward appropriate, targeted treatment.
We hope this review helps clinicians and researchers better identify and manage this often debilitating disorder.
As the field evolves, we anticipate refinements in classification and management.
Feel free to reach out with questions or to discuss further.”
Title: Monoclonal gammopathy of thrombotic significance in a nutshell
Authors: Adam J. Kanack, Emily E. Mauch, David L. Murray, Anand Padmanabhan
Read the Full Article on British Journal of Haematology
Stay updated with Hemostasis Today.
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
-
May 24, 2026, 05:48Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management
-
May 24, 2026, 05:47Ali AlBahar: The Immunologic Complexity Behind ABO Blood Grouping